XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 31,774 $ 186,138,466 $ 288,175 $ (169,523,815) $ 16,934,600
Balance (in shares) at Dec. 31, 2018 31,774,139        
Stock based compensation - employees, consultants and directors $ 0 1,174,755 0 0 1,174,755
Other comprehensive income (loss), foreign translation adjustment 0 0 868,243 0 868,243
Proceeds from exercise of stock options $ 172 728,335 0 0 728,507
Proceeds from exercise of stock options (in shares) 171,134        
Cashless exercise of warrants $ 9 (9) 0 0 0
Cashless exercise of warrants (in shares) 9,029        
Issuance of restricted stock units $ 84 663,284 0 0 663,368
Issuance of restricted stock units (in shares) 84,249        
Cashless exercise of stock options $ 22 (22) 0 0 0
Cashless exercise of stock options (in shares) 23,354        
Fees related to Open Market Sales Agreement $ 0 (87,881) 0 0 (87,881)
Proceeds from exercise of warrants $ 361 1,768,130 0 0 1,768,491
Proceeds from exercise of warrants (in shares) 360,358        
Net loss $ 0 0 0 (15,316,292) (15,316,292)
Balance at Sep. 30, 2019 $ 32,422 190,385,058 1,156,418 (184,840,107) 6,733,791
Balance (in shares) at Sep. 30, 2019 32,422,263        
Balance at Dec. 31, 2018 $ 31,774 186,138,466 288,175 (169,523,815) 16,934,600
Balance (in shares) at Dec. 31, 2018 31,774,139        
Balance at Dec. 31, 2019 $ 32,616 191,648,907 525,978 (188,789,459) 3,418,042
Balance (in shares) at Dec. 31, 2019 32,616,107        
Balance at Jun. 30, 2019 $ 32,303 189,120,749 344,655 (177,955,046) 11,542,661
Balance (in shares) at Jun. 30, 2019 32,303,231        
Stock based compensation - employees, consultants and directors $ 0 802,334 0 0 802,334
Other comprehensive income (loss), foreign translation adjustment 0 0 811,763 0 811,763
Proceeds from exercise of stock options $ 87 312,159 0 0 312,246
Proceeds from exercise of stock options (in shares) 86,600        
Issuance of restricted stock units $ 32 237,697 0 0 237,729
Issuance of restricted stock units (in shares) 32,432        
Fees related to Open Market Sales Agreement $ 0 (87,881) 0 0 (87,881)
Net loss 0 0 0 (6,885,061) (6,885,061)
Balance at Sep. 30, 2019 $ 32,422 190,385,058 1,156,418 (184,840,107) 6,733,791
Balance (in shares) at Sep. 30, 2019 32,422,263        
Balance at Dec. 31, 2019 $ 32,616 191,648,907 525,978 (188,789,459) 3,418,042
Balance (in shares) at Dec. 31, 2019 32,616,107        
Stock based compensation - employees, consultants and directors $ 0 2,863,805 0 0 2,863,805
Issuance of common stock, net of fees $ 10,163 80,203,845 0 0 $ 80,214,008
Issuance of common stock, net of fees (in shares) 10,163,256       4,301,869
Other comprehensive income (loss), foreign translation adjustment $ 0 0 (1,043,280) 0 $ (1,043,280)
Proceeds from exercise of stock options $ 298 1,281,964 0 0 1,282,262
Proceeds from exercise of stock options (in shares) 298,075        
Issuance of restricted stock units $ 88 657,692 0 0 657,780
Issuance of restricted stock units (in shares) 87,728        
Cashless exercise of stock options $ 11 (11) 0 0 0
Cashless exercise of stock options (in shares) 10,519        
Net loss $ 0 0 0 (7,159,464) (7,159,464)
Balance at Sep. 30, 2020 $ 43,176 276,656,202 (517,302) (195,948,923) 80,233,153
Balance (in shares) at Sep. 30, 2020 43,175,685        
Balance at Jun. 30, 2020 $ 36,812 218,864,425 530,447 (195,109,194) 24,322,490
Balance (in shares) at Jun. 30, 2020 36,811,870        
Stock based compensation - employees, consultants and directors $ 0 1,088,173 0 0 1,088,173
Issuance of common stock, net of fees $ 6,295 56,195,080 0 0 56,201,375
Issuance of common stock, net of fees (in shares) 6,294,998        
Other comprehensive income (loss), foreign translation adjustment $ 0 0 (1,047,749) 0 (1,047,749)
Proceeds from exercise of stock options $ 36 179,716 0 0 179,752
Proceeds from exercise of stock options (in shares) 35,823        
Issuance of restricted stock units $ 33 328,808 0 0 328,841
Issuance of restricted stock units (in shares) 32,994        
Net loss $ 0 0 0 (839,729) (839,729)
Balance at Sep. 30, 2020 $ 43,176 $ 276,656,202 $ (517,302) $ (195,948,923) $ 80,233,153
Balance (in shares) at Sep. 30, 2020 43,175,685